Literature DB >> 29567774

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.

Dhruv Bansal1, Kiran Vij1, Gue Su Chang2, Christopher A Miller2, John F DiPersio1, Ravi Vij1, Sharon E Heath1, Peter Westervelt1, John S Welch3, Todd A Fehniger3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29567774      PMCID： PMC6058793          DOI： 10.3324/haematol.2017.184168

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia.

Authors:  Todd A Fehniger; Geoffrey L Uy; Kathryn Trinkaus; Alissa D Nelson; Jeffery Demland; Camille N Abboud; Amanda F Cashen; Keith E Stockerl-Goldstein; Peter Westervelt; John F DiPersio; Ravi Vij
Journal:  Blood       Date:  2010-11-04       Impact factor: 22.113

2.  Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion.

Authors:  Virginie Chesnais; Aline Renneville; Andrea Toma; Jérôme Lambert; Marie Passet; Florent Dumont; Sylvie Chevret; Julie Lejeune; Anna Raimbault; Aspasia Stamatoullas; Christian Rose; Odile Beyne-Rauzy; Jacques Delaunay; Eric Solary; Pierre Fenaux; François Dreyfus; Claude Preudhomme; Olivier Kosmider; Michaela Fontenay
Journal:  Blood       Date:  2015-12-01       Impact factor: 22.113

3.  Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

Authors:  John S Welch; Peter Westervelt; Li Ding; David E Larson; Jeffery M Klco; Shashikant Kulkarni; John Wallis; Ken Chen; Jacqueline E Payton; Robert S Fulton; Joelle Veizer; Heather Schmidt; Tammi L Vickery; Sharon Heath; Mark A Watson; Michael H Tomasson; Daniel C Link; Timothy A Graubert; John F DiPersio; Elaine R Mardis; Timothy J Ley; Richard K Wilson
Journal:  JAMA       Date:  2011-04-20       Impact factor: 56.272

4.  Dose escalation of lenalidomide in relapsed or refractory acute leukemias.

Authors:  William Blum; Rebecca B Klisovic; Heiko Becker; Xiaoxia Yang; Darlene M Rozewski; Mitch A Phelps; Ramiro Garzon; Alison Walker; Jason C Chandler; Susan P Whitman; John Curfman; Shujun Liu; Larry Schaaf; Jon Mickle; Cheryl Kefauver; Steven M Devine; Michael R Grever; Guido Marcucci; John C Byrd
Journal:  J Clin Oncol       Date:  2010-10-18       Impact factor: 44.544

5.  Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.

Authors:  Todd A Fehniger; John C Byrd; Guido Marcucci; Camille N Abboud; Cheryl Kefauver; Jacqueline E Payton; Ravi Vij; William Blum
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

6.  Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.

Authors:  Jeffery M Klco; Christopher A Miller; Malachi Griffith; Allegra Petti; David H Spencer; Shamika Ketkar-Kulkarni; Lukas D Wartman; Matthew Christopher; Tamara L Lamprecht; Nicole M Helton; Eric J Duncavage; Jacqueline E Payton; Jack Baty; Sharon E Heath; Obi L Griffith; Dong Shen; Jasreet Hundal; Gue Su Chang; Robert Fulton; Michelle O'Laughlin; Catrina Fronick; Vincent Magrini; Ryan T Demeter; David E Larson; Shashikant Kulkarni; Bradley A Ozenberger; John S Welch; Matthew J Walter; Timothy A Graubert; Peter Westervelt; Jerald P Radich; Daniel C Link; Elaine R Mardis; John F DiPersio; Richard K Wilson; Timothy J Ley
Journal:  JAMA       Date:  2015-08-25       Impact factor: 56.272

7.  Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.

Authors:  Christopher J Hickey; Sebastian Schwind; Hanna S Radomska; Adrienne M Dorrance; Ramasamy Santhanam; Anjali Mishra; Yue-Zhong Wu; Houda Alachkar; Kati Maharry; Deedra Nicolet; Krzysztof Mrózek; Alison Walker; Anna M Eiring; Susan P Whitman; Heiko Becker; Danilo Perrotti; Lai-Chu Wu; Xi Zhao; Todd A Fehniger; Ravi Vij; John C Byrd; William Blum; L James Lee; Michael A Caligiuri; Clara D Bloomfield; Ramiro Garzon; Guido Marcucci
Journal:  Blood       Date:  2012-10-25       Impact factor: 22.113

8.  TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Authors:  John S Welch; Allegra A Petti; Christopher A Miller; Catrina C Fronick; Michelle O'Laughlin; Robert S Fulton; Richard K Wilson; Jack D Baty; Eric J Duncavage; Bevan Tandon; Yi-Shan Lee; Lukas D Wartman; Geoffrey L Uy; Armin Ghobadi; Michael H Tomasson; Iskra Pusic; Rizwan Romee; Todd A Fehniger; Keith E Stockerl-Goldstein; Ravi Vij; Stephen T Oh; Camille N Abboud; Amanda F Cashen; Mark A Schroeder; Meagan A Jacoby; Sharon E Heath; Kierstin Luber; Megan R Janke; Andrew Hantel; Niloufer Khan; Madina J Sukhanova; Randall W Knoebel; Wendy Stock; Timothy A Graubert; Matthew J Walter; Peter Westervelt; Daniel C Link; John F DiPersio; Timothy J Ley
Journal:  N Engl J Med       Date:  2016-11-24       Impact factor: 91.245

9.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

10.  pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.

Authors:  Jasreet Hundal; Beatriz M Carreno; Allegra A Petti; Gerald P Linette; Obi L Griffith; Elaine R Mardis; Malachi Griffith
Journal:  Genome Med       Date:  2016-01-29       Impact factor: 11.117
View more
  1 in total

1.  Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS.

Authors:  Joshua F Zeidner; Hanna A Knaus; Amer M Zeidan; Amanda L Blackford; Raul Montiel-Esparza; Hubert Hackl; Gabrielle T Prince; Lukasz P Gondek; Gabriel Ghiaur; Margaret M Showel; Amy E DeZern; Keith W Pratz; B Douglas Smith; Mark J Levis; Steven Gore; Catherine C Coombs; Matthew C Foster; Howard Streicher; Judith E Karp; Leo Luznik; Ivana Gojo
Journal:  Leukemia       Date:  2020-01-03       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.